Poland· PL-100174978
Suboxone
A buprenorphin, kombinationen product containing buprenorphini hydrochloridum + naloxoni hydrochloridum dihydricum, registered in Poland by Indivior Europe Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Buprenorphin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC N07BC51 (buprenorphin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Buprenorphin, kombinationen · ATC N07BC51
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Buprenorphini hydrochloridum + Naloxoni hydrochloridum dihydricum
- Manufacturer
- Indivior Europe Limited
- Country
- Poland (PL)
- ATC code
- N07BC51
- ATC class
- Buprenorphin, Kombinationen
- Defined daily dose
- 8 mg, SL
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05909990043088
- gtin05909990043095
- gtin05000158070783
- gtin05054792000002
- gtin05054792002181
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Buprenorphin, kombinationen in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesbuprenorphine and naloxoneHikma Pharmaceuticals USA Inc.
- CzechiaLIBROXARHeaton k.s., Praha
- CanadaPMS-BUPRENORPHINE-NALOXONEPHARMASCIENCE INC
- United KingdomBuprenorphine 2mg / Naloxone 500microgram sublingual tablets sugar freeAlliance Healthcare (Distribution) Ltd
- FinlandBunalictSandoz A/S
- SwedenBunalict 2 mg/0,5 mg Resoriblett, sublingualSandoz A/S
- NetherlandsBunalict 2 mg/0,5 mg, tabletten voor sublinguaal gebruikSandoz B.V.
- SpainBUPRENORFINA/NALOXONA AUROVITAS 2 MG/0,5 MG COMPRIMIDOS SUBLINGUALES EFGAurovitas Spain, S.A.U.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bupensan Duo
- Belgium · Libroxar
- Bulgaria · Булнексо
- Cyprus · Libroxar
- Czechia · Bupensanduo, Libroxar
- Germany · Bowielone, Bulnexo
- Denmark · Bunalict, Buprenorphin/Naloxon G.L. Pharma
- Estonia · Bupensanduo
- Spain · Buprenorfina/Naloxona Aurovitas
- Finland · Bunalict, Buprenorphine/Naloxone G.L. Pharma
- France · Buprenorphine / Naloxone Viatris, Buprenorphine/Naloxone Arrow
- United Kingdom (Northern Ireland) · Buprenorphine/Naloxone Ethypharm, Buprenorphine/Naloxone G.L. Pharma
- Greece · Libroxar
- Croatia · Bulnexo, Bunalict
- Hungary · Bulnexo
- Ireland · Bulexin, Buprenorphine/Naloxone Pinewood
- Iceland · Suboxone, Zubsolv
- Italy · Bunamol, Buprenorfina E Naloxone Ethypharm
- Liechtenstein · Suboxone, Zubsolv
- Lithuania · Bupensanduo
- Luxembourg · Libroxar
- Latvia · Bupensanduo
- Malta · Libroxar
- Netherlands · Bunalict, Buprenorfine/Naloxon Viatris
- Norway · Bunalict, Suboxone
- Portugal · Buprenorfina + Naloxona Generis
- Sweden · Bunalict, Buprenorphine/Naloxone G.L. Pharma
- Slovenia · Bulnexo
- Slovakia · Bupensanduo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/11e4d6b0-d52d-4c2f-b3a3-a6c2986791e2 GET /v1/drugs/11e4d6b0-d52d-4c2f-b3a3-a6c2986791e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki podjęzykowe",
"source": "urpl",
"strength": "2 mg + 0,5 mg",
"packaging": "05909990043088 ¦ Rpw ¦ Skasowane ¦ EU/1/06/359/001 ¦ 35522\n7 tabl.\n05909990043095 ¦ Rpw ¦ Skasowane ¦ EU/1/06/359/002 ¦ 35523\n28 tabl.\n05000158070783 ¦ Rpw ¦ Skasowane ¦ EU/1/06/359/001 ¦ 111026\n7 tabl.\n05054792000002 ¦ Rpw ¦ EU/1/06/359/002 ¦ 111027\n28 tabl.\n05054792002181 ¦ Rpw ¦ EU/1/06/359/001 ¦ 134885\n7 tabl.",
"substance": "Buprenorphini hydrochloridum 2 mg + Naloxoni hydrochloridum dihydricum 0.5 mg",
"common_name": "Buprenorphini hydrochloridum + Naloxoni hydrochloridum dihydricum",
"pl_product_id": "100174978",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about buprenorphin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.